1. Metab Syndr Relat Disord. 2021 Apr;19(3):127-136. doi: 10.1089/met.2020.0080. 
Epub 2020 Dec 8.

The Genetic Variants -717T>C (rs2794521), 1444G>A (rs1130864), and 1846 C > T 
(rs1205) of CRP Gene, Their Haplotypes, and Their Association with Serum CRP 
Levels, Acute Coronary Syndrome, and Diabetes in Patients from Western Mexico.

Reynoso-Villalpando GL(1)(2), Casillas-Muñoz FA(1)(2), Padilla-Gutiérrez JR(1), 
Sevillano-Collantes C(3), Moreno-Ruiz I(3), Del Cañizo-Gómez FJ(3), Valdez-Haro 
A(4), Martínez-Fernández DE(5), Valle Y(1).

Author information:
(1)Departamento de Clínicas Médicas, Instituto de Investigación en Ciencias 
Biomédicas, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de 
Guadalajara (UdG), Colonia Independencia, Guadalajara, México.
(2)Doctorado en Genética Humana, Centro Universitario de Ciencias de la Salud, 
Guadalajara, México.
(3)Sección de Endocrinología y Nutrición, Hospital Universitario Infanta Leonor, 
Facultad de Medicina, Universidad Complutense, Madrid, España.
(4)Hospital Infantil del Estado de Sonora, Departamento de Enseñanza y Calidad, 
Hermosillo, Sonora, Mexico.
(5)Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la 
Salud, Guadalajara, México.

Background: C-reactive protein (CRP) is involved in inflammatory pathways that 
are associated with the onset and progression of type 2 diabetes mellitus (T2DM) 
as well as an increased risk of an acute coronary syndrome (ACS). This research 
aimed to evaluate the potential association of the genetic variants -717T>C, 
1444G>A, and 1846 C > T of CRP gene on CRP levels, ACS, and T2DM in participants 
from Western Mexico. Methods: Six hundred three participants were studied: (1) 
control group (CG); (2) ACS participants classified as unstable angina (UA), 
myocardial infarction without ST-segment elevation (NSTEMI), and myocardial 
infarction with ST-segment elevation (STEMI); (3) T2DM Participants; and (4) ACS 
plus T2DM participants (ACS+T2DM). Genetic variants were genotyped using allelic 
discrimination with TaqMan® probes, and high-sensitivity CRP (hs-CRP) was 
measured by Turbidimetry. Results: TAC haplotype frequency was significantly 
higher in ACS+T2DM versus CG and versus ACS participants (odds ratio 
[OR] = 2.774, P = 0.017 and OR = 3.479, P = 0.020, respectively). hs-CRP levels 
were especially higher for ACS and for ACS+T2DM participants with respect to CG 
and T2DM (with P < 0.0001). We observed higher hs-CRP levels in NSTEMI and STEMI 
versus UA in ACS scenario (P = 0.001, P = 0.027, respectively) and for ACS+T2DM 
scenario (P = 0.0001, P = 0.002, respectively). Conclusion: hs-CRP level 
fluctuations are related to the presence of T2DM and the presence and severity 
of ACS. Very high levels (>10 mg/L) are a risk marker of cardiovascular 
complications. Our results demonstrate a possible relationship between TAC 
haplotype and an increased risk for T2DM and ACS.

DOI: 10.1089/met.2020.0080
PMID: 33296257 [Indexed for MEDLINE]